LeMaitre Vascular Shares Drop Despite Strong First Quarter Results

LeMaitre Vascular, Inc. reported strong fundamental performance for the first quarter of 2026, exceeding consensus estimates with an adjusted earnings per share of $0.68 against a predicted $0.66. The medical device manufacturer achieved 10% organic revenue growth and maintained gross margins of 72.1%.

Despite these results, the company's share price declined following the May 5, 2026, earnings release. Conestoga Capital Advisors attributed the drop to investors taking profits after the stock had appreciated 38% year-to-date. As of August 5, 2026, shares closed at $79.00, giving the company a market capitalization of $1.81 billion.

Conestoga Capital Advisors maintains a positive outlook on the company, citing its consistent execution and differentiated vascular product portfolio as key drivers for future revenue and earnings growth.